Nicotine strength and flavor in oral pouches and alcohol use in young adults
Official title: Assessing Co-Use of Oral Nicotine Pouches and Alcohol Among Young Adults
Run by Ohio State University Comprehensive Cancer Center · NCT07095140 · Data updated 2026-11-12
This study tests whether different nicotine strengths and flavors in oral nicotine pouches lead 21–30-year-olds to drink more, drink longer, or have different side effects during and after drinking.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 30 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | September 3, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 26, 2025 |
| Trial ID | NCT07095140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 21–30-year-olds who use oral nicotine pouches daily, drink alcohol at least three days per week, have recent experience with 6 mg ONPs, and own an iPhone for study monitoring.
✕Probably not a fit
People who do not use ONPs, drink infrequently, are pregnant or breastfeeding, use other tobacco products more than 10 days per month, or have recent cardiac or unstable psychiatric conditions are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a randomized crossover design, participants are assigned to use four types of oral nicotine pouches (low nicotine, high nicotine, unflavored, and spearmint) across four 10-day periods. During each period participants complete twice-daily ecological momentary assessments and morning-after reports when they drink, while wearing an alcohol-monitoring wristband for at least 22 hours per day. The trial enrolls daily ONP users aged 21–30 who drink alcohol at least three days per week and uses within-subject comparisons to detect effects of nicotine concentration and flavor on drinking behavior and side effects. Key exclusions include frequent use of other tobacco products, recent cardiac events, pregnancy, and unstable medical or psychiatric conditions.
Why it matters
Potential benefit: If successful, the results could clarify whether ONP nicotine strength or flavor increases alcohol use in young adults and inform product guidance and harm-reduction messaging to reduce cancer risk.
How similar studies have gone: Prior studies linking nicotine from cigarettes or e-cigarettes to increased alcohol consumption support the co-use concept, but experimental data specific to oral nicotine pouches are limited and this approach is relatively novel for pouches.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 21-30 years old * Use ONPs daily * Drink alcohol at least three days/week * Read and speak English * Own an iPhone (required for BACtrack Skyn wristband) * Used 6 mg nicotine concentration ONPs on at least 20 days of past month Exclusion Criteria: * Use of other tobacco products \> 10 days/month * Unstable or significant medical condition * Unstable or significant psychiatric conditions (past and stable conditions will be allowed) * History of cardiac event or distress within the past three months * Currently pregnant, planning to become pregnant within six months, or breastfeeding (all participants assigned female at birth will take a pregnancy test at each clinic visit before provision of study products; a negative test will be needed to proceed with product sampling)
Where it's running
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Brittney L Keller-Hamilton, PhD, MPH — Ohio State University Comprehensive Cancer Center
- Study coordinator: The Ohio State University Comprehensive Cancer Center
- Email: OSUCCCCclinicaltrials@osumc.edu
- Phone: 800-293-5066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating how acetaldehyde contributes to oral cancer development
This study is trying to see how drinking alcohol affects the development of oral cancer in healthy people and those with Fanconi anemia by looking at samples like saliva and urine.
-
Body-focused mindfulness added to inpatient alcohol use disorder treatment
This trial tests whether a body-focused mindfulness program can help people with alcohol use disorder feel more connected to their bodies and reduce cravings while in inpatient care.
-
CARRII Native Intervention Optimization: Finding the Best Online Help for Native Women at Risk of Alcohol-Exposed Pregnancy
This trial tests different online components of CARRII to see which mix best reduces risk of alcohol-exposed pregnancy among Native women who could become pregnant and drink.
-
Support for psychiatric clinics to increase prescribing of medicines for alcohol use disorder
This project will test whether providing outside facilitation, training, and clinic-level supports in three psychiatric clinics helps clinicians prescribe medications for people with major mental illness who also have alcohol use disorder.
-
Helping Veterans with chronic disease reduce smoking and risky drinking
This program will test whether a mailed, tailored education packet plus a brief motivational phone call helps Veterans with diabetes, heart disease, or related risk factors who smoke or drink too much become more motivated to change.
-
Comparing two therapies for alcohol addiction
This study is testing which therapy, Combined Behavioral Intervention or Ericksonian Hypnotherapy, works better to help adults with alcohol addiction reduce their drinking and improve their overall well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.